title: Three-year outcome in a patient with Staphylococcus lugdunensis discitis.
abstract: The few reported cases of bone and joint infection by Staphylococcus lugdunensis indicate that the clinical manifestations are severe, the diagnosis elusive, and the treatment difficult. We report a case of lumbar discitis caused by Staphylococcus lugdunensis in a 67-year-old man receiving chemotherapy for stage III IgA lambda multiple myeloma. Treatment was with ofloxacin and pristinamycin for 1 year. Although he started to improve only 5 months after treatment initiation, the outcome was favorable. Follow-up at the time of this writing is 3 years.
authors.affiliation: Rheumatology department, hĵpital de la Conception, Marseilles, France.
authors.forename: Mildreth
authors.initials: M
authors.lastname: Camacho
authors.forename: Sandrine
authors.initials: S
authors.lastname: Guis
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Mattei
authors.forename: Régis
authors.initials: R
authors.lastname: Costello
authors.forename: Jean
authors.initials: J
authors.lastname: Roudier
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D015299:Discitis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D006801:Humans; D016867:Immunocompromised Host; D008159:Lumbar Vertebrae / Q000382:microbiology / Q000473:pathology*; D008297:Male; D008826:Microbial Sensitivity Tests; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology; D015242:Ofloxacin / Q000627:therapeutic use; D025762:Pristinamycin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D013210:Staphylococcus / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D025762:Pristinamycin; D015242:Ofloxacin